Integrated Stent Delivery System: A Next Generation of Stent Delivery and Drug-Eluting Stent
Highlights
- • The SLENDER Integrated Delivery System (IDS™) is an ‘all-in-one’ coronary stenting device combining an interventional guide wire, low-compliant delivery balloon and DES
- • IDS may allow downsizing catheters and facilitate transradial intervention (TRI), reducing the risk of bleeding complications, morbidity and mortality while improving time to ambulation and patient comfort
- • Direct stenting with an IDS streamlines stent delivery and may convey patient benefits, including reduced radiation exposure and intervention time, myocardial infarction (MI) and death, compared with conventional stenting in suitable lesions
- • A large scale, multi-center study (n=1,630) in the US, Japan and EU is being undertaken to establish the safety and efficacy of SLENDER IDS in a randomized setting
Abstract
The SLENDER Integrated Delivery System (IDS™) is an ‘all-in-one’ fixed-wire coronary stenting device designed for direct stenting, precluding the need for conventional guidewires and predilatation balloons. It achieves ultra-low profiles (crossing profiles as low as 0.029″/0.737 mm), enabling the downsizing of catheters to facilitate transradial intervention in a large subsets of patients. The IDS represents the first advance in coronary stent delivery since the introduction of rapid-exchange stent delivery systems >20 years ago. SLENDER IDS has demonstrated non-inferiority compared with commercial DES, excellent long-term safety and a potentially more efficient approach to PCI where patient comfort is enhanced, procedures are streamlined, and resource consumption is reduced. This paper will summarize the novel features of this new stent delivery system and the early clinical data demonstrating safety and efficacy.